HHS. I thought it was an ok quarter. Definitely signs of an inflexion happening. Smallest y/y decline in revenue in the past 5 quarters; now finally profitable, and they comfortably beat the one estimate I saw out there for a loss of 0.06 in the quarter. I had them earning 0.14/sh adjusted, and taxed at 20%. The stock is dirt cheap....its Ev/EBITDA ratio is 2.2x. Cost savings of 6MM coming in the remainder of the year, plus some signals on the call of revenue growth resuming in Q3 or Q4. If they can do this, they should earn well north of 1.00/sh. I hope it does sell off a bit.
News 
Market Data 
Discover 
AI
